This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Estrogen receptor 3D structures
From Proteopedia
(Difference between revisions)
(New page: ==3D structures of estrogen receptor== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *Estrogen receptor α ligand...) |
|||
| Line 15: | Line 15: | ||
**[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | **[[2q6j]], [[2p15]], [[3erd]], [[1l2i]] - hERα LBD + GRIP peptide<br /> | ||
**[[6d0f]], [[6czn]] - hERα LBD (mutant) + GRIP peptide<br /> | **[[6d0f]], [[6czn]] - hERα LBD (mutant) + GRIP peptide<br /> | ||
| - | **[[6cbz]], [[5wgq]], [[5wgd]] - hERα LBD (mutant) + GRIP peptide + | + | **[[6cbz]], [[5wgq]], [[5wgd]] - hERα LBD (mutant) + GRIP peptide + EST<br /> |
| + | **[[6pit]] - hERα LBD (mutant) + stapled peptide + EST<br /> | ||
**[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | **[[4q13]] - hERα LBD (mutant) + glucocorticoid receptor-interacting protein peptide<br /> | ||
| + | **[[6vig]] - hERα LBD + anti-hormone<br /> | ||
| + | **[[6vj1]] - hERα LBD (mutant) + anti-hormone<br /> | ||
**[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | **[[5krf]] - hERα LBD (mutant) + peptide + anti-hormone<br /> | ||
**[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | **[[2yat]] - hERα LBD (mutant) + EST derivative<br /> | ||
| Line 22: | Line 25: | ||
**[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]], [[6chz]], [[6chw]], [[6c42]], [[6b0f]], [[5w9d]], [[5ufx]], [[5ufw]] - hERα LBD (mutant) + antagonist<br /> | **[[5fqp]], [[5fqr]], [[5fqs]], [[5fqt]], [[5fqv]], [[5aau]], [[5aav]], [[5acc]], [[5ak2]], [[5di7]], [[5did]], [[5die]], [[5dig]], [[5dk9]], [[5dkb]], [[5dke]], [[5dkg]], [[5dks]], [[5dl4]], [[5dlr]], [[5dmc]], [[5dmf]], [[5dp0]], [[6chz]], [[6chw]], [[6c42]], [[6b0f]], [[5w9d]], [[5ufx]], [[5ufw]] - hERα LBD (mutant) + antagonist<br /> | ||
**[[6owc]] - hERα LBD (mutant) + pyridine derivative<br /> | **[[6owc]] - hERα LBD (mutant) + pyridine derivative<br /> | ||
| - | **[[4q50]], [[5w9c]] - hERα LBD (mutant) + tamoxifen derivative<br /> | + | **[[4q50]], [[5w9c]], [[6v87]] - hERα LBD (mutant) + tamoxifen derivative<br /> |
**[[3uuc]] - hERα LBD + bisphenol<br /> | **[[3uuc]] - hERα LBD + bisphenol<br /> | ||
| + | **[[6pet]] - hERα LBD + hydroxychromene<br /> | ||
| + | **[[6pfm]] - hERα LBD (mutant) + hydroxychromene<br /> | ||
| + | **[[6psj]] - hERα LBD (mutant) + osteoporosis drug<br /> | ||
| + | **[[6wok]] - hERα LBD + breast cancer drug<br /> | ||
| + | **[[6suo]] - hERα LBD + indole derivative<br /> | ||
| + | **[[6sq0]] - hERα LBD (mutant) + indole derivative<br /> | ||
| + | **[[6v8t]] - hERα LBD (mutant) + benzothiophene derivative<br /> | ||
| + | **[[6vjd]], [[6vmu]], [[6vnn]], [[6vpk]], [[6vvp]] - hERα LBD + modulator<br /> | ||
| + | **[[6vgh]] - hERα LBD (mutant) + modulator<br /> | ||
**[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | **[[5t1z]] - hERα LBD + LXXLL motif (mutant) + ethoxy triphenylethylene<br /> | ||
**[[1gwr]] - hERα LBD + TIF2 peptide + EST<br /> | **[[1gwr]] - hERα LBD + TIF2 peptide + EST<br /> | ||
| Line 75: | Line 87: | ||
**[[1x7r]] - hERα LBD + NCAO3 peptide + genistein<br /> | **[[1x7r]] - hERα LBD + NCAO3 peptide + genistein<br /> | ||
**[[1x7e]] - hERα LBD + NCAO3 peptide + ligand<br /> | **[[1x7e]] - hERα LBD + NCAO3 peptide + ligand<br /> | ||
| + | |||
| + | *Estrogen receptor α DNA binding domain | ||
| + | |||
| + | **[[1hcp]] – hERα DBD – NMR<br /> | ||
| + | **[[1hcq]], [[4aa6]] – hERα DBD + DNA<br /> | ||
| + | |||
| + | **[[6sbo]] – hERα residues 124-381 + pyrrolydin derivative<br /> | ||
*Estrogen receptor β ligand binding domain | *Estrogen receptor β ligand binding domain | ||
| Line 94: | Line 113: | ||
**[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + NCAO peptide + ligand<br /> | **[[1x76]], [[1x78]], [[1x7b]], [[1yy4]], [[1yye]], [[1zaf]], [[2j7y]], [[2nv7]], [[3omo]], [[3omp]], [[3omq]] - hERβ LBD + NCAO peptide + ligand<br /> | ||
**[[1x7j]] - hERβ LBD + NCAO peptide + genistein | **[[1x7j]] - hERβ LBD + NCAO peptide + genistein | ||
| - | |||
| - | *Estrogen receptor α DNA binding domain residues 182-252 | ||
| - | |||
| - | **[[1hcp]] – hERα DBD – NMR<br /> | ||
| - | **[[1hcq]], [[4aa6]] – hERα DBD + DNA<br /> | ||
}} | }} | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:29, 23 July 2020
3D structures of estrogen receptor
Updated on 23-July-2020
